期刊文献+

不稳定性心绞痛患者介入治疗围术期CD4 T淋巴细胞磷酸酶基因表达的变化 被引量:2

PTEN expression in CD4 T lymphocytes of unstable angina pectoris patients during perioperative PCI
下载PDF
导出
摘要 目的:探讨不稳定性心绞痛患者PCI围术期CD4 T淋巴细胞张力蛋白同源第10染色体丢失的磷酸酶基因(PTEN )表达的变化。方法连续入选拟行择期PCI的不稳定性心绞痛患者42例,分别于PCI术前、术后16~24 h抽取新鲜外周血20 ml ,免疫磁珠法分选出CD4 T淋巴细胞,荧光定量PCR检测PTEN mRNA表达,蛋白免疫印迹法检测PTEN蛋白表达,酶联免疫吸附法检测 TNF-α及白细胞介素10(IL-10)炎性相关因子的表达。结果与PCI术前比较,PCI术后患者肌钙蛋白I高于正常高值的发生率为45.4%;与PCI术前比较,PCI术后血浆TNF-α水平明显升高,PTEN mRNA、PTEN蛋白和IL-10明显下降,差异有统计学意义(P<0.05,P<0.01)。直线相关分析显示,PTEN蛋白与TNF-α呈负相关(r=-0.874,P<0.01),与IL-10呈正相关(r=0.732,P<0.05)。结论PCI术可能通过下调PT EN的表达,促进相关炎性因子的分泌,从而诱发心肌炎症损伤。 Objective To study the PTEN expression in CD4 T lymphocytes of unstable angina pectoris patients during perioperative PCI .Methods Forty-two unstable angina pectoris patients who were going to undergo PCI were enrolled in this study .Peripheral blood samples were taken before and 16-24 h after PCI .CD4 T lymphocytes were isolated using the magnetic cell sorting system .Expression of PTEN mRNA and protein was detected by RFQ-PCR and Western blot respectively .Serum levels of TNF-α and IL-10 were measured by ELISA .Results The incidence of cTnI was 45 .4% higher while the expression level of PTEN mRNA and protein was significantly lower after PCI than before PCI .The serum TNF-αlevel was significantly higher while the serum IL-10 level was significantly lower after PCI than before PCI (P〈0 .05 ,P〈0 .01) .Linear correlation analysis showed that PTEN protein expression was negatively related with serum TNF-αlevel (r= -0 .874 ,P〈0 .01) and positively related with serum IL-10 level (r= 0 .732 ,P〈0 .05) . Conclusion PCI promotes secretion of inflammatory factors by down-regulating PTEN expres-sion ,thus inducing myocardial inflammation injury .
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2014年第6期577-579,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(81260042 81260046)
关键词 心绞痛 不稳定型 CD4阳性T淋巴细胞 肿瘤坏死因子α 白细胞介素10 PTEN磷酸水解酶 angina, unstable CD4-positive T-lymphocytes tumor necrosis factoralpha interleukin-10 troponin I PTEN phosphohydrolase
  • 相关文献

参考文献1

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2124

同被引文献19

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部